OBJECTIVE: To assess the effects of growth hormone (GH) treatment combined with cognitive rehabilitation in patients with adult growth hormone deficiency (GHD) and cognitive disorders occurring after traumatic brain injury (TBI). PARTICIPANTS: Nineteen adult patients with TBI: GHD was found in 11 of them. INTERVENTION: Patients were treated with GH (GHD; sc; 1 mg/day) or vehicle (controls; sc; 1 mg/day); daily cognitive rehabilitation therapy was performed in both groups for 3 months. MAIN OUTCOME MEASURES: The GHRH-arginine test established GHD. The neuropsychological test WAIS was performed before commencing the treatment and 3 months after commencing it. RESULTS: Controls achieved significant improvements in digits and in manipulative intelligence quotient (IQ) (p < 0.05 vs. baseline). GHD achieved significant improvements in more cognitive parameters: understanding, digits, numbers and incomplete figures (p < 0.05 vs. baseline) and similarities, vocabulary, verbal IQ, manipulative IQ and total IQ (p < 0.01). GHD reached significantly greater improvements than controls in similarities (p < 0.01) and in vocabulary, verbal IQ and total IQ (p < 0.05). CONCLUSION: GH administration significantly improved cognitive rehabilitation in GHD patients. Since at the end of treatment period plasma IGF-I levels were similar in both groups it is likely that exogenous GH administration is responsible for the significant differences found.
OBJECTIVE: To assess the effects of growth hormone (GH) treatment combined with cognitive rehabilitation in patients with adult growth hormone deficiency (GHD) and cognitive disorders occurring after traumatic brain injury (TBI). PARTICIPANTS: Nineteen adult patients with TBI: GHD was found in 11 of them. INTERVENTION: Patients were treated with GH (GHD; sc; 1 mg/day) or vehicle (controls; sc; 1 mg/day); daily cognitive rehabilitation therapy was performed in both groups for 3 months. MAIN OUTCOME MEASURES: The GHRH-arginine test established GHD. The neuropsychological test WAIS was performed before commencing the treatment and 3 months after commencing it. RESULTS: Controls achieved significant improvements in digits and in manipulative intelligence quotient (IQ) (p < 0.05 vs. baseline). GHD achieved significant improvements in more cognitive parameters: understanding, digits, numbers and incomplete figures (p < 0.05 vs. baseline) and similarities, vocabulary, verbal IQ, manipulative IQ and total IQ (p < 0.01). GHD reached significantly greater improvements than controls in similarities (p < 0.01) and in vocabulary, verbal IQ and total IQ (p < 0.05). CONCLUSION: GH administration significantly improved cognitive rehabilitation in GHD patients. Since at the end of treatment period plasma IGF-I levels were similar in both groups it is likely that exogenous GH administration is responsible for the significant differences found.
Authors: Adriana G Ioachimescu; Benjamin M Hampstead; Anna Moore; Elizabeth Burgess; Lawrence S Phillips Journal: Pituitary Date: 2015-08 Impact factor: 4.107
Authors: Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer Journal: J Neurotrauma Date: 2014-01-15 Impact factor: 5.269
Authors: David J Barton; Raj G Kumar; Emily H McCullough; Gary Galang; Patricia M Arenth; Sarah L Berga; Amy K Wagner Journal: J Head Trauma Rehabil Date: 2016 Jul-Aug Impact factor: 2.710
Authors: Traver Wright; Randall Urban; William Durham; E Lichar Dillon; Kathleen M Randolph; Christopher Danesi; Charles Gilkison; Christof Karmonik; Dennis J Zgaljardic; Brent Masel; James Bishop; Richard Pyles; Rachael Seidler; Ashton H Hierholzer; Melinda Sheffield-Moore Journal: J Neurotrauma Date: 2020-01-17 Impact factor: 5.269
Authors: Margarita Heredia; Virginia Sánchez-Robledo; Inés Gómez; José María Criado; Antonio de la Fuente; Jesús Devesa; Pablo Devesa; Adelaida Sánchez Riolobos Journal: Int J Mol Sci Date: 2021-05-21 Impact factor: 5.923